NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE72906 Query DataSets for GSE72906
Status Public on Oct 01, 2015
Title Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer [SET 14]
Organism Homo sapiens
Experiment type Genome variation profiling by SNP array
SNP genotyping by SNP array
Summary Sporadic breast cancer (SBC) is a common and heterogeneous disease. There is no reliable way of early prediction of risk for SBC in the general population. We studied 282 females with SBC concentrating on copy number aberrations in tumor-free breast tissue (uninvolved margin, UM) outside the area of primary tumor (PT). Totally 1162 UMs (1-14 per breast) were studied. PT and blood/skin as control was also analyzed. Comparative analysis between genetic profiles for UM(s), PT(s) and blood/skin from the same patient is the core of study design. We identified 108 patients with at least one aberrant UM specimen, representing 38.3% of all cases. Gains were the dominating mutations in microscopically normal breast cells and gain of ERBB2, with overexpression of HER2 protein, was the most common aberration in normal cells. Five additional receptor genes (EGFR, FGFR1, IGF1R, LIFR and NGFR) also showed gains, and these were occasionally present in combination with the gain of ERBB2. Up to 67.6% of patients showed gain of one or more of these genes in normal cells. The aberrations found in normal cells from UMs were previously described in cancer literature, which suggest their causative, driving role in this disease. We demonstrate that analysis of normal cells from cancer-bearing patients leads to identification of genetic signatures that may predispose to SBC. Early detection of signals suggesting a predisposition towards development of SBC, long before detectable tumors are formed, is a key to the anticipated shift into a preventive paradigm of personalized medicine of breast cancer.
 
Overall design We studied 282 female breast cancer patients that were assessed as affected by sporadic disease at the time of diagnosis and all underwent mastectomy. In total, 1162 UMs (uninvolved margin tissues), ranging from 1 to 14 UMs per patient, taken outside the location of clinically characterized index primary tumor, were analyzed on Illumina arrays. For each subject, DNA from at least one control tissue was also analyzed, which was predominantly blood DNA, alternatively skin-derived DNA. We also studied primary tumor (PT), or up to 3 primary tumor foci from patients with diagnosis of multifocal disease. This GEO project contains the genotyping profiles (processed and normalized data including Log R Ratio and B allele frequency) for these 1162 UMs used in the study. Information on phenotypes (age at diagnosis, tumor focality, tumor grade, tumor molecular phenotype) is also provided, whenever available. This subSeries represents 108 controls (genotype data from whool blood/skin ) from subject showing at least one UM sample with aberration.
[23_controls_GPL6984.txt] 23 control experiments (blood/skin tissue) run on the platform GPL6984 (Human1M-Duov3_B)
[2_controls_GPL13135.txt] 2 control experiments (blood/skin tissue) run on the platform GPL13135 (HumanOmniExpress BeadChip).
[5_controls_GPL18636.txt] 5 control experiments (blood/skin tissue) run on the platform GPL18636 (Illumina Human660W-Quad v1.0). Please note that GPL18636 on GEO has chromosome coordinates in genome buid 36. In the matrix table I'm maintaining the same IDs as on GEO, but the chromosomal positions (“Position_hg19”) is reported in chromosomal build 37. I did this to provide with experiments which can be directly compared with all the others, which are run on platforms that already support chromosome build 37.
[78_controls_GPL18224.txt] 78 control experiments (blood/skin tissue) run on the platform GPL18224 (Infinium HumanOmniExpressExome).
 
Contributor(s) Rasi C
Citation(s) 26430163
Submission date Sep 10, 2015
Last update date Dec 31, 2015
Contact name Chiara Rasi
E-mail(s) chiara.rasi@igp.uu.se
Phone +46 739443230
Organization name Uppsala University
Department Department of Immunology, Genetics and Pathology
Street address Husargatan 3
City Uppsala
State/province Sweden
ZIP/Postal code 75123
Country Sweden
 
Platforms (4)
GPL6984 Illumina Human1M-Duov3 DNA Analysis BeadChip (Human1M-Duov3_B)
GPL13135 HumanOmniExpress BeadChip
GPL18224 Infinium HumanOmniExpressExome BeadChip
Samples (108)
GSM1874269 BK9K_1
GSM1874270 JD67K_2
GSM1874271 ML36K_3
This SubSeries is part of SuperSeries:
GSE64732 Post-zygotic structural variants in histologically normal breast tissue may predispose to sporadic breast cancer.
Relations
BioProject PRJNA295305

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE72906_23_controls_GPL6984.txt.gz 420.9 Mb (ftp)(http) TXT
GSE72906_2_controls_GPL13135.txt.gz 25.7 Mb (ftp)(http) TXT
GSE72906_5_controls_GPL18636.txt.gz 53.3 Mb (ftp)(http) TXT
GSE72906_78_controls_GPL18224.txt.gz 1.0 Gb (ftp)(http) TXT
GSE72906_RAW.tar 116.3 Mb (http)(custom) TAR
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap